Polygenic heterogeneity in antidepressant treatment and placebo response
Por um escritor misterioso
Descrição
Challenges and opportunities associated with rare-variant
Understanding genetic risk factors for common side effects of
Genome-wide association study and polygenic risk score analysis of
Frontiers Shared Genetic Liability and Causal Associations
Baseline clinical features. A Summary of key clinical features in
Common genetic variation and antidepressant efficacy in major
Evidence-based guidelines for treating depressive disorders with
Pharmacogenomics — Drug Disposition, Drug Targets, and Side
Frontiers Association of the Polygenic Scores for Personality
Results of the study of Leuchter et al. (2014), confirming that
de
por adulto (o preço varia de acordo com o tamanho do grupo)
